AI Verdict
GBX has stronger fundamentals based on our AI analysis.
GCAN vs GBX Fundamental Comparison
| Metric | GCAN | GBX |
|---|---|---|
| Revenue | $12,630.0 | $706.1M |
| Net Income | $-669,369.0 | $36.4M |
| Net Margin | -5,299.8% | 5.2% |
| ROE | N/A | 2.4% |
| ROA | -3,134.5% | 0.8% |
| Current Ratio | 0.02x | N/A |
| Debt/Equity | N/A | 1.15x |
| EPS | $-0.85 | $1.14 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GCAN vs GBX: Frequently Asked Questions
Is GCAN or GBX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GBX has stronger fundamentals. GCAN is rated STRONG SELL (95% confidence) while GBX is rated HOLD (62% confidence). This is not investment advice.
How does GCAN compare to GBX fundamentally?
Greater Cannabis Company, Inc. has ROE of N/A vs GREENBRIER COMPANIES INC's 2.4%. Net margins are -5,299.8% vs 5.2% respectively.
Which stock pays higher dividends, GCAN or GBX?
GCAN has a dividend yield of N/A or no dividend while GBX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GCAN or GBX for long term?
For long-term investing, consider that GCAN has STRONG SELL rating with 95% confidence, while GBX has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GCAN vs GBX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GCAN vs GBX, the AI consensus favors GBX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.